Federal Register / Vol. 86, No. 23 / Friday, February 5, 2021 / Notices 8381 

2All contract personnel will sign appropriate 

nondisclosure agreements. 

3Electronic Document Information System 

(EDIS): https://edis.usitc.gov. 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) By the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel,2 solely for cybersecurity 

purposes. All nonconfidential written 

submissions will be available for public 

inspection at the Office of the Secretary 

and on EDIS.3

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and of §§ 201.10 and 210.8(c) of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.10, 210.8(c)). 

By order of the Commission. 

Issued: February 1, 2021. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2021–02435 Filed 2–4–21; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–772] 

Bulk Manufacturer of Controlled 

Substances Application: Sterling 

Pharma USA, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Sterling Pharma USA LLC has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplemental Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before April 6, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

April 6, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on January 5, 2021, 

Sterling Pharma USA, LLC., 1001 

Sheldon Drive, Suite 101, Cary, North 

Carolina 27513–2078, applied to be 

registered as an bulk manufacturer of 

the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug 

code Schedule 

Tetrahydrocannabinols ............... 7370 I 

The company plans to manufacture in 

bulk drug code 7370 

(Tetrahydrocannabinols) exclusively 

from hemp extract, for distribution and 

sale to its customers. No other activity 

for this drug code is authorized for this 

registration. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–02455 Filed 2–4–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–771] 

Bulk Manufacturer of Controlled 

Substances Application: Noramco, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Noramco Inc has applied to 

be registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before April 6, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

April 6, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on November 3, 2020, 

Noramco Inc, 1550 Olympic Drive, 

Athens Georgia 30601, applied to be 

registered as an bulk manufacturer of 

the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric Acid .... 2010 I 

Marihuana Extract ..................... 7350 I 

Marihuana ................................. 7360 I 

Tetrahydrocannabinols ............. 7370 I 

Codeine-N-oxide ....................... 9053 I 

Dihydromorphine ....................... 9145 I 

Hydromorphinol ......................... 9301 I 

Nabilone .................................... 7379 II 

Codeine ..................................... 9050 II 

Dihydrocodeine ......................... 9120 II 

Oxycodone ................................ 9143 II 

Hydromorphone ........................ 9150 II 

Hydrocodone ............................. 9193 II 

Levorphanol .............................. 9220 II 

Morphine ................................... 9300 II 

The company plans to manufacture 

bulk active pharmaceutical ingredients 

(API) and reference standards for 

distribution to their customers. 

In reference to drug codes 7350 

(Marihuana Extract), 7360 (Marihuana), 

and 7370 (Tetrahydrocannabinols), the 

company plans to bulk manufacture 

these drugs as synthetics. No other 

activities for these drugs are authorized 

for this registration. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–02454 Filed 2–4–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

[OMB Number 1125–NEW] 

Agency Information Collection 

Activities; Proposed Collection; 

Comments Requested; FOIAXpress/ 

FOIA Public Access Link 

AGENCY: Executive Office for 

Immigration Review, Department of 

Justice. 

ACTION: 30-day notice. 

SUMMARY: The Department of Justice 

(DOJ), Executive Office for Immigration 

Review (EOIR), will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. 


jbell on DSKJLSW7X2PROD with NOTICES
8382 Federal Register / Vol. 86, No. 23 / Friday, February 5, 2021 / Notices 

DATES: Comments are encouraged and 

will be accepted for an additional 30 

days until March 8, 2021. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

If you need a copy of the proposed 

information collection or additional 

information, please contact Lauren 

Alder Reid, Assistant Director, Office of 

Policy, Executive Office for Immigration 

Review, 5107 Leesburg Pike, Suite 2500, 

Falls Church, VA 22041, telephone: 

(703) 305–0289. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and/or 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

New collection. 

2. The Title of the Form/Collection: 

FOIAXpress Public Access Link. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

No agency form number, electronic 

collection. The applicable component of 

the Department of Justice is the Office 

of the General Counsel, Executive Office 

for Immigration Review. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Members of the public seeking 

to obtain records from the Executive 

Office for Immigration Review (EOIR). 

Abstract: This information collection is 

necessary to communicate with the 

requester community electronically 

regarding agency record requests and 

deliver agency records electronically 

subject to disclosure to the requester 

community. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: It is estimated that 33,984 

respondents will complete FOIA 

requests via FOIAXpress with an 

average of 3 minutes per response. 

6. An estimate of the total public 

burden (in hours) associated with the 

collection: There are an estimated 1,699 

total annual burden hours associated 

with this collection. 

If additional information is required 

contact: Melody Braswell, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, 3E.405B, 

Washington, DC 20530. 

Dated: February 1, 2021. 

Melody D. Braswell, 

Department Clearance Officer for PRA, U.S 

Department of Justice. 

[FR Doc. 2021–02381 Filed 2–4–21; 8:45 am] 

BILLING CODE 4410–30–P 

NATIONAL ARCHIVES AND RECORDS 

ADMINISTRATION 

[NARA–21–0002; NARA–2021–013] 

Records Schedules; Availability and 

Request for Comments 

AGENCY: National Archives and Records 

Administration (NARA). 

ACTION: Notice of availability of 

proposed records schedules; request for 

comments. 

SUMMARY: The National Archives and 

Records Administration (NARA) 

publishes notice of certain Federal 

agency requests for records disposition 

authority (records schedules). We 

publish notice in the Federal Register 

and on regulations.gov for records 

schedules in which agencies propose to 

dispose of records they no longer need 

to conduct agency business. We invite 

public comments on such records 

schedules. 

DATES: NARA must receive comments 

by March 22, 2021. 

ADDRESSES: You may submit comments 

by either of the following methods. You 

must cite the control number, which 

appears on the records schedule in 

parentheses after the name of the agency 

that submitted the schedule. 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. 

• Mail: Records Appraisal and 

Agency Assistance (ACR); National 

Archives and Records Administration; 

8601 Adelphi Road; College Park, MD 

20740–6001. 

FOR FURTHER INFORMATION CONTACT: 

Kimberly Keravuori, Regulatory and 

External Policy Program Manager, by 

email at regulation_comments@

nara.gov. For information about records 

schedules, contact Records Management 

Operations by email at 

request.schedule@nara.gov, by mail at 

the address above, or by phone at 301– 

837–1799. 

SUPPLEMENTARY INFORMATION: 

Public Comment Procedures 

We are publishing notice of records 

schedules in which agencies propose to 

dispose of records they no longer need 

to conduct agency business. We invite 

public comments on these records 

schedules, as required by 44 U.S.C. 

3303a(a), and list the schedules at the 

end of this notice by agency and 

subdivision requesting disposition 

authority. 

In addition, this notice lists the 

organizational unit(s) accumulating the 

records or states that the schedule has 

agency-wide applicability. It also 

provides the control number assigned to 

each schedule, which you will need if 

you submit comments on that schedule. 

We have uploaded the records 

schedules and accompanying appraisal 

memoranda to the regulations.gov 

docket for this notice as ‘‘other’’ 

documents. Each records schedule 

contains a full description of the records 

at the file unit level as well as their 

proposed disposition. The appraisal 

memorandum for the schedule includes 

information about the records. 

We will post comments, including 

any personal information and 

attachments, to the public docket 

unchanged. Because comments are 

public, you are responsible for ensuring 

that you do not include any confidential 

or other information that you or a third 

party may not wish to be publicly 

posted. If you want to submit a 

comment with confidential information 

or cannot otherwise use the 

regulations.gov portal, you may contact 

request.schedule@nara.gov for 

instructions on submitting your 

comment. 

We will consider all comments 

submitted by the posted deadline and 


jbell on DSKJLSW7X2PROD with NOTICES